dropboxuser
8,783
edits
No edit summary |
No edit summary |
||
Line 115: | Line 115: | ||
| Wed Apr 27 | | Wed Apr 27 | ||
| | | | ||
| '''Use of modular, synthetic scaffolds for improved production of glucaric acid in engineered E. coli.'''Moon TS et al. ''Metabolic Engineering'' (2010) 12: 298-305 (2010) [[ | | '''Use of modular, synthetic scaffolds for improved production of glucaric acid in engineered E. coli.'''Moon TS et al. ''Metabolic Engineering'' (2010) 12: 298-305 (2010) [[PMID: 20117231]] | ||
|'''Production of the antimalarial drug precursor artemisinic acid in engineered yeast'''<br>Ro DK, et al. ''Nature'' (2006) 440, 940–943 <br>[[PMID: 16612385]] | |'''Production of the antimalarial drug precursor artemisinic acid in engineered yeast'''<br>Ro DK, et al. ''Nature'' (2006) 440, 940–943 <br>[[PMID: 16612385]] | ||
|-- | |-- |